Seven Days In March: NDA-BLA and ANDA Approval Output Diverged As Coronavirus Teleworking Began

 
• By Derrick Gingery
  
Machinery cogwheels, industry concept
The coronavirus outbreak forced changes to FDA workflow and priorities, which may have affected NDA-BLA approval output. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet